Related Experiment Video
Updated: Mar 1, 2026
04:00
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
1.4K
Geriatric oncology in 2040: Exploring potential realities and challenges. A diverse perspective
Raymond Gardner1, Luciola Pontes Leite de Barros2, Kwok Leung Cheung3
1The Royal Marsden NHS Foundation Trust, London, UK.
Journal of Geriatric Oncology
|February 27, 2026
Summary
Global life expectancy is rising, increasing cancer in older adults. This paper synthesizes challenges and opportunities in geriatric oncology, focusing on innovation, equity, and patient-centered care for the next decade.
Area of Science:
- Geriatric Oncology
- Public Health
- Healthcare Innovation
Background:
- Global life expectancy is projected to reach 80 years by 2040, leading to an increased prevalence of cancer, a disease associated with aging.
- The growing population of older adults with cancer necessitates advancements in service delivery, multidisciplinary collaboration, and patient-centered care.
Purpose of the Study:
- To explore the realities and challenges of an aging population with cancer.
- To provide a strategic resource for policymakers, healthcare leaders, clinicians, and patients on navigating demographic shifts and technological advancements in geriatric oncology.
- To promote equity, innovation, quality, and resilience in cancer care for older adults.
Main Methods:
- Multidimensional lens analysis of demographic shifts, technological advancements, and evolving patient needs.
- Synthesis of expert perspectives on impending challenges in geriatric oncology.
- Identification of key areas including precision medicine, digital health, healthcare delivery models, workforce training, and resource allocation.
Main Results:
- Anticipation of increased disparities in care for older adults with cancer.
- Emphasis on the importance of personalized interventions and enhancing quality of life.
- Highlighting the need for adapted healthcare delivery models and workforce training.
Conclusions:
- Strategic planning is crucial to address the rising burden of cancer in an aging global population.
- Innovation in precision medicine, digital health, and patient-centered approaches is essential.
- Collaboration among stakeholders is vital to ensure equitable and resilient geriatric oncology care for the future.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
302
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
302
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
288
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288